CXCR4: A New Player in an Old Scene?
Andreas Knopf1, Marie Kristin Fritsche, Yin Li
1Hals-Nasen-Ohrenklinik und Poliklinik, Technische Universität München, Munich, Germany.
Abstract:
Transmembrane C-X-C chemokine receptor 4 (CXCR4) and its ligand C-X-C motif chemokine 12 (CXCL12) came into focus in many solid cancers, allowing a more fundamental diagnostic and therapeutic approach by modulating the immune response against cancer cells. CXCR4 and CXCL12 mediate cell proliferation, migration, and metastatic outgrowth in head and neck squamous cell carcinoma (HNSCC) and are strongly associated with cancer recurrence and patient survival. Despite recent advances in molecular imaging and cancer therapy in lymphoma using CXCL12 analogues, clinical trials evaluating the diagnostic and therapeutic impact on HNSCC are missing.
More Related Videos
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Chemotaxis and Direction of Cell Migration
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
Intracellular Signaling Affects Focal Adhesions
Some...
GPCRs Regulate Adenylyl Cylase Activity
Cell Polarization by Rho Proteins


